A randomized, double-blind, placebo-controlled phase 2 study of an oral p38α MAPK inhibitor, SCIO-469, in patients with active rheumatoid arthritis

被引：0

作者：

Genovese, M. C. ^{[1
]}

Cohen, S. B. ^{[2
]}

Wofsy, D. ^{[3
]}

Weinblatt, M. E. ^{[4
]}

Firestein, G. S. ^{[5
]}

Brahn, E. ^{[6
]}

Strand, V. ^{[7
]}

Baker, D. G. ^{[8
]}

Tong, S. E. ^{[9
]}

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] Metroplex Clin Res Ctr, Dallas, TX USA

[3] Univ Calif San Francisco, San Francisco, CA 94143 USA

[4] Brigham & Womens Hosp, Boston, MA 02115 USA

[5] Univ Calif San Diego, San Diego, CA 92103 USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Stanford Univ, Portola Valley, CA USA

[8] Centocor Inc, Malvern, PA 19355 USA

[9] Scios J&J PRD, Mountain View, CA USA

来源：

ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S431 / S432

页数：2

共 50 条

[31] EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN MUSCULOSKELETAL MANIFESTATIONS OF ACTIVE PSORIATIC ARTHRITIS IN A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Mease, P. J.
Deodhar, A.
Van der Heijde, D.
Behrens, F.
Kivitz, A.
Lehman, T.
Wei, L.
Nys, M.
Banerjee, S.
Nowak, M.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 137 - 138
[32] Filtration leukocytapepheresis therapy in rheumatoid arthritis - A randomized, double-blind, placebo-controlled trial
Hidaka, T
Suzuki, K
Matsuki, Y
Takamizawa-Matsumoto, M
Kataharada, K
Ishizuka, T
Kawakami, M
Nakamura, H
ARTHRITIS AND RHEUMATISM, 1999, 42 (03): : 431 - 437
[33] MINOCYCLINE IN ACTIVE RHEUMATOID-ARTHRITIS (RA) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
KLOPPENBURG, M
BREEDVELD, FC
TERWIEL, JP
MALLEE, C
DIJKMANS, BAC
ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S47 - S47
[34] Efficacy, Pharmacodynamics, and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rheumatoid Arthritis Results of Two Randomized, Double-Blind, Placebo-Controlled Clinical Studies (vol 60, pg 1232, 2009)
Damjanov
ARTHRITIS AND RHEUMATISM, 2009, 60 (10): : 3071 - 3071
[35] EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Mease, P. J.
Deodhar, A.
Van der Heijde, D.
Behrens, F.
Kivitz, A.
Kim, J.
Singhal, S.
Nowak, M.
Banerjee, S.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 314 - 315
[36] Oral type II collagen treatment in early rheumatoid arthritis - A double-blind, placebo-controlled, randomized trial
Sieper, J
Kary, S
Sorensen, H
Alten, R
Eggens, U
Huge, W
Hiepe, F
Kuhne, A
Listing, J
Ulbrich, N
Braun, J
Zink, A
Mitchison, NA
ARTHRITIS AND RHEUMATISM, 1996, 39 (01): : 41 - 51
[37] Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
Stohl, William
Merrill, Joan T.
McKay, James D.
Lisse, Jeffrey R.
Zhong, Z. John
Freimuth, William W.
Genovese, Mark C.
JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 579 - 589
[38] SINGLE INFUSION WITH APD IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
EGGELMEIJER, F
PAPAPOULOS, S
DIJKMANS, B
BREEDVELD, F
ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S57 - S57
[39] Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
van Dongen, Henrike
van Aken, Jill
Lard, Leroy R.
Visser, Karen
Ronday, H. Karel
Hulsmans, Harry M. J.
Speyer, Irene
Westedt, Marie-Louise
Peeters, Andre J.
Allaart, Cornelia F.
Toes, Rene E. M.
Breedveld, Ferdinand C.
Huizinga, Tom W. J.
ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1424 - 1432
[40] MULTIENZYME THERAPY IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF MULSAL IN PATIENTS WITH RHEUMATOID-ARTHRITIS
BANDILLA, K
EWALD, RW
HEIMSTADT, P
STROHMANN, I
ZEITSCHRIFT FUR RHEUMATOLOGIE, 1986, 45 (04): : 231 - 232

← 1 2 3 4 5 →